Skip to main content
Log in

To Set Up Norms for Drug Safety and Inspection: To Guarantee Administrative Sufficiency and Avoid Regulators from Being Wrongly Punished

  • Review Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Currently, as there is no systematic norm or standard for drug safety and inspection, it cannot be judged whether the regulatory authority or regulators have fulfilled their administrative responsibilities entirely or not, when a drug safety-related incident occurs. And there is a probability that some may even be wrongly punished. In this study, we have analyzed the risk of not having appropriate norms in place and also put forward recommendations for the government or the regulatory authorities to set up norms to be fulfilled for drug safety and inspection issues. This, on one hand, could provide a basic guideline for the regulatory authorities and regulators to improve their professional levels and administrative acumen and on the other hand, it could also provide a baseline for society to judge whether the regulatory authorities and regulators have fulfilled their responsibilities correctly and thereby also help prevent regulators from being mistakenly punished. This study proposes that a systematic and functional norm for drug safety and inspection could be set up relating to the determination of the responsibilities of regulatory authorities and scope of various inspections, number and frequency of inspections, number and qualifications of regulators, handling of inspection results, inspection records, and disciplinary codes for inspectors. This study also puts forward suggestions on who should be responsible for drafting the norms and what are the factors that need to be considered while formulating the norms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Yu, Xuan, Li, Cheng, Shi, Yuhua, & Yu, Min. (2010). Pharmaceutical supply chain in China: Current issues and implications for health system reform. Health Policy, 97, 8–15.

    Article  PubMed  Google Scholar 

  2. Jinpeng, Zhao, & Guozhong, Feng. (2012). The present situation and the bottleneck analysis of Chinese pharmaceutical development. Modern Business Trade Industry, 8, 25–26.

    Google Scholar 

  3. (2006). Editors, Twenty one persons were punished for “Qieryao” counterfeit drugs event. The Mirror, 7, 20.

  4. (2013). Applicable law issues explanation of handling criminal cases of dereliction of duty, Gazette of the Supreme People’s Procuratorate of the People’s Republic of China, 02, 20–21.

  5. (2005).Measures for the supervision over and administration of pharmaceutical production, Gazette of the State Council of the People’s Republic of China, 17, 36–40.

  6. yanfang, Ma., & Yi, Liang. (2010). The investigation of the present problem of drug GMP inspector. Journal of China Prescription Drug, 97, 69–71.

    Google Scholar 

  7. On the issuance of pharmaceutical GMP certification administrative measures, SFDA, http://www.sda.gov.cn/WS01/CL0844/64569_3.html. Accessed 2 Aug 2011.

  8. Yuan, Liu, Jun, Bi, & Yi, Zhou. (2011). The comparison of domestic and foreign drug GMP inspector regulation. China Pharmacist, 14, 870.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mingli Shao.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xuan, Q., Dong, Z. & Shao, M. To Set Up Norms for Drug Safety and Inspection: To Guarantee Administrative Sufficiency and Avoid Regulators from Being Wrongly Punished. Cell Biochem Biophys 73, 1–5 (2015). https://doi.org/10.1007/s12013-015-0568-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-015-0568-x

Keywords

Navigation